PI
SRPT icon

Putnam Investments’s Sarepta Therapeutics SRPT Stock Holding History

Putnam Investments’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20,332
Closed -$2.46M – 1219
2023
Q3 		$2.46M Sell
20,332
-34,388
-63% -$3.89M ﹤0.01% 678
2023
Q2 		$6.27M Sell
54,720
-27,930
-34% -$3.6M 0.01% 408
2023
Q1 		$11.4M Sell
82,650
-24,668
-23% -$3.2M 0.02% 286
2022
Q4 		$13.9M Sell
107,318
-7
-0% -$811 0.02% 242
2022
Q3 		$11.9M Buy
107,325
+50,725
+90% +$5.11M 0.02% 262
2022
Q2 		$4.24M Buy
+56,600
New +$4.16M 0.01% 479
2021
Q1 		– Sell
-38,560
Closed -$6.57M – 839
2020
Q4 		$6.57M Sell
38,560
-1,129
-3% -$167K 0.01% 452
2020
Q3 		$5.57M Sell
39,689
-28,957
-42% -$4.4M 0.01% 460
2020
Q2 		$11M Sell
68,646
-50,854
-43% -$6.92M 0.02% 313
2020
Q1 		$11.7M Buy
119,500
+41,200
+53% +$4.71M 0.03% 288
2019
Q4 		$10.1M Buy
+78,300
New +$7.9M 0.02% 364
2019
Q3 		– Sell
-29,438
Closed -$4.47M – 939
2019
Q2 		$4.47M Sell
29,438
-953
-3% -$116K 0.01% 542
2019
Q1 		$3.62M Sell
30,391
-2,769
-8% -$356K 0.01% 595
2018
Q4 		$3.62M Hold
33,160
– – 0.01% 525
2018
Q3 		$5.36M Buy
33,160
+18,312
+123% +$2.5M 0.01% 547
2018
Q2 		$1.96M Sell
14,848
-8,984
-38% -$847K ﹤0.01% 727
2018
Q1 		$1.77M Buy
23,832
+1,100
+5% +$73.3K ﹤0.01% 741
2017
Q4 		$1.26M Buy
22,732
+5,358
+31% +$284K ﹤0.01% 855
2017
Q3 		$788K Buy
+17,374
New +$694K ﹤0.01% 947

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Putnam Investments's SRPT Position: Q4 2023 in Review

Putnam Investments sold out of Sarepta Therapeutics (SRPT) in Q4 2023, closing a stake of 20,332 shares — an estimated $2.46M sold.

Putnam Investments first reported a position in SRPT in Q3 2017 and held it in 19 quarters. The position peaked at $13.9M in Q4 2022. 395 funds tracked by Wall St. Rank hold SRPT as of Q4 2023.

  • Putnam Investments reported no remaining Sarepta Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Putnam Investments sold 20,332 Sarepta Therapeutics shares in Q4 2023, an estimated $2.46M.
  • Putnam Investments first reported a position in Sarepta Therapeutics in Q3 2017 and held it in 19 quarters.
  • Putnam Investments's Sarepta Therapeutics position peaked at $13.9M in Q4 2022.
  • 395 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.